PEDIATRICS Vol. 107 No. 3 March 2001, pp. 595-597
Received Jan 1, 2000; accepted Jun 5, 2000.
Department of Pediatrics University of Calgary Calgary Alberta T2N 2T9 Canada
We report on a 35-week gestation infant who developed severe hyponatremia and thrombocytopenia after continuous infusion of glucagon for the treatment of intractable hypoglycemia. Given these serious side effects, glucagon infusion should be avoided in the treatment of premature infants.hypoglycemia, glucose, small for gestational age.
.
This article has been cited by other articles:
![]() |
D. S. Charsha, P. S. McKinley, and J. M. Whitfield Glucagon Infusion for Treatment of Hypoglycemia: Efficacy and Safety in Sick, Preterm Infants Pediatrics, January 1, 2003; 111(1): 220 - 221. [Full Text] [PDF] |
||||
![]() |
R. E. Miralles, A. Lodha, M. Perlman, and A. M. Moore Experience With Intravenous Glucagon Infusions as a Treatment for Resistant Neonatal Hypoglycemia Arch Pediatr Adolesc Med, October 1, 2002; 156(10): 999 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G Coulthard, E. N Hey, and J. Belik Glucagon Is Very Unlikely to Have Caused Hyponatremia Pediatrics, May 1, 2002; 109(5): 985 - 985. [Full Text] [PDF] |
||||